Ironwood Pharmaceuticals (IRWD) Asset Utilization Ratio (2011 - 2026)

Ironwood Pharmaceuticals (IRWD) has 16 years of Asset Utilization Ratio data on file, last reported at 0.87 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 7.19% year-over-year to 0.87; the trailing twelve-month figure through Mar 2026 stood at 0.87 (down 7.19% YoY), and the FY2025 full-year result was 0.79, down 7.37% from the prior year.
• Asset Utilization Ratio advanced to 0.87 in Q1 2026, from 0.75 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.96 in Q3 2024 to a low of 0.37 in Q1 2023.
• A 5-year average of 0.72 and a median of 0.87 in 2026 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio plunged 44.42% in 2022 and soared 145.79% in 2024, its largest moves.
• Tracing IRWD's Asset Utilization Ratio over 5 years: stood at 0.38 in 2022, then soared by 131.97% to 0.89 in 2023, then advanced by 6.68% to 0.95 in 2024, then fell by 21.31% to 0.75 in 2025, then gained by 16.42% to 0.87 in 2026.
• Business Quant data shows IRWD's Asset Utilization Ratio at 0.87 in Q1 2026, 0.75 in Q4 2025, and 0.92 in Q3 2025.